PHARMACEUTICAL APPROACHES OF IL-6 INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, FOCUS ON NEW FDA APPROVED DRUG: SARILUMAB
Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 1
Abstract
Rheumatoid arthritis (RA) is a chronic inf1ammatory disease of unknown etiology and the most common form of chronic inflammatory arthritis and often results in joint damage and physical disability. RA is characterized by synovial inflammation and hyperplasia, autoantibody production, cartilage and bone destruction, and systemic features, including cardiovascular, pulmonary, psychological, and skeletal disorders. Interleukin-6 (IL-6) is a potent pro-inflammatory agent which plays a crucial role in the pathogenesis of systemic inflammatory disease. During acute inflammation in RA, monocytes, macrophages and endothelial cells release IL-6, accompanied by an increase in neutrophils in synovial fluids. As disease progresses, IL-6 is thought to influence the shift from acute to chronic inflammation. Recently, the agents targeting the IL-6 (classes of biologic therapies) and/or its receptor attracted significant attention as a promising arthritics drug. RA patients with inadequate response to TNF inhibitor and non-biologic disease modifying anti-rheumatic drugs (DMARDs), demonstrated a therapeutic response to IL-6 receptor blockers. This article attempts to review the new FDA approved IL-6 inhibitor drug Sarilumab for RA from pharmaceutical aspects.
Authors and Affiliations
Reza Andriani
Keywords
Related Articles
- EP ID EP666930
- DOI -
- Views 103
- Downloads 0
AWARENESS AND ATTITUDE TOWARDS BASIC LIFE SUPPORT (BLS) AMONG STUDENTS AT MAJMMAH UNIVERSITY: STATISTICAL STUDY
A statistical study was performed to evaluate and analyze the awareness of the students at Majmmah university about the basic life support (BLS). A questionnaire model of 20 questions covering the basic points of the sub...
STEVENS-JOHNSON SYNDROME: A CASE REPORT AND LITERATURE REVIEW
The Stevens-Johnson disorder resembles a fractional thickness burns that may cause a 100% loss of epidermis, requiring a regeneration as a severe burn.[1] The case of interest was 62 years old female who is suffering fro...
A REVIEW ON “NEW GENERATION EXCIPIENTS OF MULTIFUNCTIONAL NOVAL DOSAGE FORM”
In a Present Study of Pharmacy Co-processing is the way that new excipients approaching to the market without undergoing accurate safety testing of completely new chemical. It can be defined as combining two or more esta...
POTENTIAL AND COMPARATIVE TESTS OF CEFADROXILE ANTIBIOTICS AS EVALUATION OF THE QUALITY OF ANTIBIOTICS IN CASES OF ANTIBIOTIC RESISTANCE
Objective: Acute Respiratory Infection (ARI) is an acute infection of any part of the respiratory tract including the paranasal sinuses, middle ear, and pleural cavity. Cefadroxile antibiotics are one of the antibiotics...
METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF SAROGLITAZAR IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC
A simple, sensitive and rapid reverse phase high performance liquid chromatographic method was developed for the estimation of Saroglitazar in tablet dosage form. A C18 Inertsil ODS column (250 × 4.6 mm, 5μm particle siz...